In a stunning move led by U.S. Senate majority leader Mitch McConnell (R-Ky), the United States Senate has now passed legislation that ends hemp prohibition and would allow farmers across the nation to cultivate hemp.
“The bill would legalize hemp, removing it from the federal list of controlled substances and allowing it to be sold as an agricultural commodity,” reports The Hill.
|
Earlier today the New York State Court of Appeals, New York’s highest court, released an unanimous decision supporting a New York City Board of Health regulation from 2013 requiring annual flu shots for children in pre-schools and daycare regulated by the City, overturning a lower court ruling, and a 5-0 Appellate division decision, rejecting the City’s claim that it had the authority to impose its own vaccine mandates. No further appeal is possible.
The City’s regulation applies to children age 6 to 59 months, and only those programs under the supervision of the City of New York. Many daycare and pre-school programs are under the supervision of the New York State. Children at state supervised programs are not bound by the regulation. The Court recognized in the decision that religious and medical exemptions apply to the flu shot requirement.
The decision appears to open the door to local governments across New York State to mandate vaccines in addition to those required by state law. New York City now joins Connecticut and New Jersey as the only places in the United States, and the developed democracies, that require flu shots.
|
NY State Court of Appeals Adjudication document court of appeals – flu shot mandate – 64opn18-Decision
The team looked at five years’ worth of private health insurance data for children between the ages of six and 15. They found that “young people vaccinated in the previous three to 12 months were significantly more likely to be diagnosed with certain neuropsychiatric disorders than their non-vaccinated counterparts.” READ More…
Study PDF download below
All Psychiatric 0-5 Years 622,723
Drugs
Breakdown:
0-1 Years 125,361
2-3 Years 202,319
4-5 Years 306,079
6-12 Years 3,259,955
13-17 Years 3,419,633
ADHD Drugs 0-5 Years 80,235
Breakdown:
0-1 Years 328
2-3 Years 1,919
4-5 Years 77,396
6-12 Years 2,119,343
13-17 Years 1,524,381
Grand Total 0-17 Years 3,655,472 kids on ADHD Drugs
Antidepressants 0-5 Years 38,534
Breakdown:
0-1 Years 6,687
2-3 Years 10,957
4-5 Years 21,299
6-12 Years 574,090
13-17 Years 1,503,185
Grand Total 0-17 Years 2,100,315 kids on antidepressants
Antipsychotics 0-5 Years 85,143
Breakdown:
0-1 Years 3,913
2-3 Years 27,001
4-5 Years 53,750
6-12 Years 467,500
13-17 Years 646,215
Grand Total 0-17 Years 1,194,805 kids on antipsychotics
Anti-anxiety 0-5 Years 389,558
Breakdown:
0-1 Years 102,960
2-3 Years 148,894
4-5 Years 143,692
6-12 Years 484,612
3-17 Years 577,259
Grand Total 0-17 Years 1,445,509 kids on anti-anxiety drugs
VLA COMMENT: This was published in 2013. Prescription drug use as increased since then.
Because they are getting 49 vaccine doses with vaccine excipents that cannot be metabolized, causing poisoning and damage to their neurology, immune system, depression, suicide as young as seven years old…hanging from a belt in his closet or dangling from the canopy. See: www.SSRISTORIES.NET
Learn more about the mechanics: PHARMACOGENOMICS/SUICIDES, HOMICIDES AND SCHOOL VIOLENCE.
IMPORTANCE: Prescription medications are increasingly used among adults in the United
States and many have a potential for causing depression.
OBJECTIVES: To characterize use of prescription medications with depression as a potential
adverse effect and to assess associations between their use and concurrent depression.
Prescription medications are widely and increasingly
used in the United States, with approximately 15% of
adults estimated to have been using 5 or more concurrent
prescription medications in 2011 and 2012.1 Alongside evidence
that adverse drug events from prescription medications
are often implicated in emergency department visits and
hospitalizations,2 there is gaining recognition thatmany commonlyused
prescriptionmedications, includinghormonalcontraceptives
and β-blockers, are associated with an increased
risk of depression.
CONCLUSION: In this cross-sectional survey study, use of prescription
medications that have depression as a potential adverse effect was common. Use of multiple
medications was associated with greater likelihood of concurrent depression.
Read study: JAMA_drugs_linked_to_depression(1)
Must read: Pharmacogentics, Suicide, Homicide and school violence
List of sucides and homicides on psychiatric drugs: www.SSRIStories.net
Objective: The aim of this study was to examine the association between the CYP2D6 and CYP2C19 genotypepredicted combined phenotypes and short-term measures of psychotropic efficacy and toxicity.
Methods: A rater-blinded, retrospective genotype association design examined a cohort of hospitalized pediatric psychiatric patients genotyped for CYP2D6 and CYP2C19 as part of clinical care. These combined genotypes were used to predict a combined phenotype. The primary efficacy outcome measure was the behavior intervention score (BIS), a function of the number of recorded timeouts=seclusions, therapeutic holds, and physical restraints.
Drug tolerability was defined as the total number of recorded adverse drug reactions.
Pharmacogentics, Suicide, Homicide and school violence
Accounts of thousand of Suicides and Homicides: www.SSRIStories.net
In a cooperative agreement starting January 1995, prior to the FDA’s licensure of the varicella vaccine on March 17, the Centers for Disease Control and Prevention (CDC) funded the Los Angeles Department of Health Services’ Antelope Valley Varicella Active Surveillance Project (AV-VASP). Since only varicella case reports were gathered, baseline incidence data for herpes zoster (HZ) or shingles was lacking.
Goldman VaricellaAntelopeValley
VLA COMMENT: The near eradication of the early childhood Chicken Pox has resulted in people who have had natural wild chickenpox as children are not getting their”subtle” exongenous boosters from the subsequent generation of our children or our grandchildren who unfortunately are prevented from getting wild chicken pox, They are getting vaccinated with a different strain that can’t boost us. So, in essence, the CDC has simply brought another chicken pox strain into existence. Now we have two. However, the wild typeis not prevelant enough to give us the necessary booster so we don’t get shingles.
The only reason that “children who get the chickenpox vaccine APPEAR to have a much lower risk of shingles” is that the live vaccine has provided these children with a recent boost to their immunity. However, the vaccine-strain of varicella zoster virus (VZV)–also known as the Oka strain–is genetically different from the wild-type U.S. strain. When a vaccinated child is exposed to an adult with shingles or a child with wild-type varicella, if the strains are sufficiently heterologous, the vaccinated child will break out in chickenpox. It is also possible for the weakened vaccine-strain to revert to a more virulent strain that manifests wild-type pathology. This means when children are exposed to the wild-type strain, even though they may not have a breakthrough infection with chickenpox, they now harbor two heterologous (genetically different) strains of VZV–both of which are at a later time subject to reactivation as shingles. Thus, as they age, they will be even more likely to reactivate with shingles (unless periodically administered booster vaccine doses for life in order to maintain the immunity)–especially if they do not receive exogenous (outside) boosts to their cell-mediated immunity which, in the pre-vaccine era, came from expostures to other children infected with wild-type varicella which provided the adult with a subclinical boost that helped to suppress or postpone reactivattion of shingles.
I would also like to clear up the point that shingles has always been increasing–even prior to the licensing of the varicella vaccine. This statement is true; however, the increases were on the order of 2 to 4% per year (which were likely due to an aging population, or greater access to healthcare). Once a community had widespread distribution of varicella vaccine, increases in herpes zoster were on the order of 20% per year. For example, this source [Yih WK, Brooks DR, Lett SM, et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 2005; 5:68.
32. Schmid DS, Jumaan AO. Impact of varicella vaccine on varicella-zoster virus dynamics. Clin Microbiol Rev 2010; 23(1):202–217] found a 90% increase in shingles over 5 years (1999-2003).
